FA
MED icon

Financial Advantage’s Medifast MED Stock Holding History

Financial Advantage’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-180
Closed -$5K – 129
2014
Q2 		$5K Hold
180
– – ﹤0.01% 107
2014
Q1 		$5K Hold
180
– – ﹤0.01% 112
2013
Q4 		$5K Hold
180
– – ﹤0.01% 186
2013
Q3 		$5K Hold
180
– – ﹤0.01% 168
2013
Q2 		$5K Buy
+180
New +$4.73K ﹤0.01% 169

Other funds holding MED

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
GGPE
Golden Gate Private Equity San Francisco, California $241M AUM 13.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Financial Advantage's MED Position: Q3 2014 in Review

Financial Advantage sold out of Medifast (MED) in Q3 2014, closing a stake of 180 shares — an estimated $5K sold.

Financial Advantage first reported a position in MED in Q2 2013 and held it in 5 quarters. The position peaked at $5K in Q2 2014. 124 funds tracked by Wall St. Rank hold MED as of Q3 2014.

  • Financial Advantage reported no remaining Medifast position as of Q3 2014 after selling out during the quarter.
  • Financial Advantage sold 180 Medifast shares in Q3 2014, an estimated $5K.
  • Financial Advantage first reported a position in Medifast in Q2 2013 and held it in 5 quarters.
  • Financial Advantage's Medifast position peaked at $5K in Q2 2014.
  • 124 funds tracked by Wall St. Rank held Medifast as of Q3 2014.

Based on Financial Advantage's 13F filing for Q3 2014, filed 12 Nov 2014.